Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Sleeping in darkness vs no treatment Serious adverse events · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Specially processed cereals vs placebo Improvement in vertigo · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Specially processed cereals vs placebo Change in vertigo · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Specially processed cereals vs placebo Serious adverse events · Ménière’s disease Lifestyle and dietary interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Intratympanic gentamicin vs no treatment/placebo Serious adverse events · Ménière’s disease Intratympanic gentamicin for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Positive pressure therapy vs placebo Serious adverse events · adults with Ménière’s disease Positive pressure therapy for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Ventilation tubes vs no treatment Change in frequency of vertigo · Ménière’s disease Surgical interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Ventilation tubes vs no treatment Serious adverse events · Ménière’s disease Surgical interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Endolymphatic sac decompression vs placebo (sham surgery) Serious adverse events · adults with Ménière’s disease Surgical interventions for Ménière’s disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Adenoidectomy and unilateral ventilation tube vs unilateral ventilation tube only Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Adenoidectomy for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Adenoidectomy and unilateral ventilation tube vs unilateral ventilation tube only Adverse event: haemorrhage · children aged 6 months to 12 years with otitis media with effusion (OME) Adenoidectomy for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Adenoidectomy and ventilation tubes vs no treatment/watchful waiting Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Adenoidectomy for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Adenoidectomy (with or without myringotomy) vs no treatment/watchful waiting Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Adenoidectomy for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Adenoidectomy and bilateral ventilation tubes vs bilateral ventilation tubes only Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Adenoidectomy for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs placebo Disease‐specific quality of life · children (aged 6 months to 12 years) with otitis media with effusion (OME) Antibiotics for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics vs no treatment Disease‐specific quality of life · children (aged 6 months to 12 years) with otitis media with effusion (OME) Antibiotics for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Topical (intranasal) steroids vs no treatment Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Topical and oral steroids for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Topical (intranasal) steroids vs no treatment Adverse event: systemic corticosteroid side effects · children aged 6 months to 12 years with otitis media with effusion (OME) Topical and oral steroids for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Oral steroids vs no treatment Hearing · children aged 6 months to 12 years with otitis media with effusion (OME) Topical and oral steroids for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Oral steroids vs no treatment Disease‐specific quality of life · children aged 6 months to 12 years with otitis media with effusion (OME) Topical and oral steroids for otitis media with effusion (OME) in children (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Deterioration to severe wasting · children aged > 6 months and ≤ 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Appropriate identification of children with wasting · children aged > 6 months and ≤ 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Appropriate identification of children with oedema · children aged > 6 months and ≤ 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Appropriate referral of children with moderate or severe wasting · children aged > 6 months and ≤ 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Treatment coverage · children aged > 6 months and ≤ 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Caregiver adherence to care plans · children aged > 6 months and ≤ 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects and other harms · children aged > 6 months and ≤ 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Sustained recovery · children aged > 6 months and < 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Relapse · children aged > 6 months and < 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Deterioration to severe wasting · children aged > 6 months and < 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Appropriate identification of children with wasting · children aged > 6 months and < 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Appropriate identification of children with oedema · children aged > 6 months and < 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Appropriate referral of children with moderate or severe wasting · children aged > 6 months and < 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Caregiver adherence to care plans · children aged > 6 months and < 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects and other harms · children aged > 6 months and < 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Sustained recovery · children aged > 6 months and ≤ 5 years with wasting Lay health workers in primary and community health care for maternal and child health: identification and… (2023) · Cochrane | no estimate extracted | NR | No studies |
Dietary intervention (probiotics) vs placebo Improvement in vertigo · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Vestibular rehabilitation vs no treatment Serious adverse effects · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Dietary intervention (probiotics) vs placebo Serious adverse events · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behavioural therapy (CBT) vs no treatment Improvement in vertigo · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behavioural therapy (CBT) vs no treatment Serious adverse events · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Vestibular rehabilitation vs no treatment Improvement in vertigo · adults with vestibular migraine Non‐pharmacological interventions for prophylaxis of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Triptans vs placebo Change in vertigo · adults with acute attacks of vestibular migraine Pharmacological interventions for acute attacks of vestibular migraine (2023) · Cochrane | no estimate extracted | NR | No studies |
Transcranial direct current stimulation vs placebo Improvement in vertigo at 3 to ≤ 6 months · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Vestibular rehabilitation vs placebo or no treatment Serious adverse events · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Vestibular rehabilitation vs placebo or no treatment CI: confidence interval · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Transcranial direct current stimulation vs placebo Change in vertigo at 3 to ≤ 6 months · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Talking therapies or stress management vs placebo or no treatment Improvement in vertigo at 3 to ≤ 6 months · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Talking therapies or stress management vs placebo or no treatment Change in vertigo at 3 to ≤ 6 months · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |
Talking therapies or stress management vs placebo or no treatment Serious adverse events · adults with PPPD Non‐pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) (2023) · Cochrane | no estimate extracted | NR | No studies |